Migraine attacks are a problem for millions of Americans each year, but the long-term impact of this sometimes debilitating condition has been unclear. Now a new study published in the International Journal of Geriatric Psychiatry suggests that migraine, the most common neurological d

A new study reveals impaired insulin signaling in the brain negatively affects cognition, memory and learning. The findings shed light on why those with type 2 diabetes are at greater risk of developing Alzheimer’s disease. Source: Joslin Diabetes Center. Scientists continue to find e

By Liji Thomas, MD The use of transcranial direct current stimulation (tDCS) has been hampered by the lack of knowledge to its long-term adverse effects and by the potential misuse of the technology due to its very ease of its application. Despite the restrictions on the widespread us

Abstract Atrophy of the medial temporal lobe (MTL) occurs with aging, resulting in impaired episodic memory. Aerobic fitness is positively correlated with total hippocampal volume, a heavily studied memory-critical region within the MTL. However, research on associations between seden

LONDON, July 16, 2017 /PRNewswire-USNewswire/ — Research reported at the Alzheimer’s Association International Conference (AAIC) 2017 in London highlighted the clinical value of amyloid-β PET scans, which detect the presence of amyloid-beta plaques in the brain – one

Alzheimer’s Association (http://www.alz.org) recently released its 2017 Alzheimer’s Disease Facts and Figures. The NeuroCognitive Institute is an active site of clinical trials for Alzheimer’s Disease. Clinical trials are the best way for researchers to find new ways to de

Neurim Pharmaceuticals announces first patients’ enrollments in ReCOGNITION – phase II clinical trial of Piromelatine for mild Alzheimer’s disease Tel Aviv, Israel, September 14, 2016 Neurim Pharmaceuticals (“Neurim”) announced today that the first patients hav